Home
Conditions
Purpura

Clinical trial condition

Purpura

Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.

377 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Purpura trial results

Recruiting

Leflunomide for Henoch-Schonlein Purpura

NCT05937880

Conditions: Blood Coagulation Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia

NCT05937828

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: CHU Amiens Picardie Service d' Onco-Immuno-Hématologie Pédiatrique Amiens, France

CHU d'Angers Unité d'Hémato-Oncologie Pédiatrique Angers, France

BESANCON CHU de Besançon Hôpital Jean MINJOZ Unité d'Hémato-Oncologie Pédiatrique, Pédiatrie 1 Besançon, France

CHU de Bordeaux - Unité d'Hématologie et d'Oncologie pédiatrique Bordeaux, France

View Trial Details

Recruiting

Construction of a Database for TTP

NCT05571774

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations: the first affiliated hospital of Soochow university Suzhou, Jiangsu, China

View Trial Details

Enrolling by Invitation

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

NCT06723106

Conditions: Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations: Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

Westmead Hospital Sydney, New South Wales, Australia

Campbelltown Public Hospital Sydney, New South Wales, Australia

The Alfred Hospital Melbourne, Victoria, Australia

View all 62 locations

View Trial Details

Enrolling by Invitation

Comparative Autoantibody and Immunologic Cell Marker Study

NCT02422875

Conditions: Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, +85 more
Locations: Emory University Hospital Atlanta, Georgia, United States

Emory University Winship Cancer Institute Atlanta, Georgia, United States

Grady Health System Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus

NCT07680010

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +20 more
Locations: Chu de Bordeaux- Groupe Hospitalier Pellegrin - Hôpital des Enfants Bordeaux, France

CHU Toulouse - Hôpital des Enfants Toulouse, France

View Trial Details

Not Yet Recruiting

A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

NCT07700238

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program

NCT07429942

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP

NCT07687134

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

rhTPO Dose Escalation vs Eltrombopag Switch in ITP

NCT07476846

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Purpura

Purpura trial results

Related conditions